What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting

被引:51
|
作者
Rolnick, SJ [1 ]
Kopher, R [1 ]
Jackson, J [1 ]
Fischer, LR [1 ]
Compo, R [1 ]
机构
[1] HealthPartners Res Fdn, Res, Minneapolis, MN 55440 USA
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2001年 / 8卷 / 02期
关键词
osteoporosis education; bone mineral density; hormone replacement; postmenopausal;
D O I
10.1097/00042192-200103000-00010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess whether osteoporosis education, with and without bone mineral density (BMD) testing, increases the initiation of lifestyle changes and pharmaceutical treatment to prevent osteoporosis. Design: A total of 508 women, aged 54-65, from a large managed care organization who were not on osteoporosis prevention therapy participated in an intervention study. Participants were randomly assigned to either an education class on osteoporosis (n = 301) or education plus BMD (n = 207). A control group of 187 women receiving no intervention were also surveyed to serve as comparison. Group differences and differences based on BMD test result were compared 6 months after education regarding self-reported changes in health behaviors using chi (2) tests and logistic regression analyses. Results: Of the 508 intervention participants, 455 (90%) responded to the follow-up survey. Initiation of hormone replacement therapy was reported by 9%, with 5% reporting starting alendronate. More than half reported changes in diet, exercise, or calcium intake. Forty-three percent increased their vitamin D intake. There were no significant group differences in behavior except with regard to pharmaceutical therapy; subjects with education plus BMD were three times more likely than those receiving education only to report starting hormone replacement therapy (p = 0.004). Low BMD scores were associated with increasing vitamin D intake (p = 0.03) and starting medication (p = 0.001). Women in the intervention groups were significantly more likely to report modifying their diet (p < 0.001), calcium (p < 0.01), and vitamin D intake (p < 0.0001) than women in the control group, not exposed to education. Conclusion: Education regarding osteoporosis prevention seems to encourage women to make lifestyle changes. The inclusion of BMD testing enhances the likelihood that women will consider pharmaceutical therapy.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 50 条
  • [41] A comparison of risk factors and bone mineral density measurements in Turkish postmenopausal women with osteoporosis
    Ofluoglu, D
    Kul, E
    Gunduz, OH
    Akyuz, G
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S90 - S90
  • [42] Effects of romosozumab on low bone mineral density or osteoporosis in postmenopausal women: a systematic review
    Chen, Wenxiang
    Yang, Huiying
    Jiang, Xuesheng
    ANNALS OF JOINT, 2020, 5 (02):
  • [43] Two years neridronate increases bone mineral density in postmenopausal women affected by osteoporosis
    Filipponi, P
    Cristallini, S
    Frediani, B
    Policani, G
    Schifim, MF
    Garinei, P
    BONE, 2002, 30 (03) : 48S - 48S
  • [44] Metabolomics-based analysis of plasma in postmenopausal women with normal bone mineral density, postmenopausal osteoporosis, and rheumatoid arthritis osteoporosis
    Zhu, Kun
    Zhang, Ju
    Zhang, Changchun
    Zhao, Shufang
    Gao, Jie
    Guan, Jianzhong
    ALL LIFE, 2023, 16 (01)
  • [45] Bone Mineral Density in Premenopausal and Postmenopausal Women
    Qureshi, Hamid Javiad
    Hamid, Naila
    Bashir, Muhammad Usman
    Saleem, Tahira
    Awan, Ayesha Rasool
    Rooh-Ul-Ain
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 203 - 205
  • [46] Overview of bone mineral density in postmenopausal women
    Notelovitz, M
    JOURNAL OF REPRODUCTIVE MEDICINE, 2002, 47 (01) : 71 - 81
  • [47] Adiponectin and bone mineral density in postmenopausal women
    Richards, J. B.
    Valdes, A. M.
    Burling, K.
    Perks, U.
    Spector, T. D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S23 - S23
  • [48] BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH HYPERTENSION
    Vele, P.
    Simon, S. -P.
    Muntean, L.
    Fodor, D.
    Rednic, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1074 - 1074
  • [49] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Atmaca, Aysegul
    Gedlik, Olcay
    ADVANCES IN THERAPY, 2006, 23 (06) : 842 - 853
  • [50] Evaluation of sex steroids, bone turnover markers, bone mineral density in Saudi postmenopausal women with osteoporosis
    Ardawi, MMSM
    Nasrat, HAN
    Bahksh, TM
    Maimany, AA
    Syamik, AY
    Milaat, WA
    BONE, 2005, 36 : S385 - S385